The effect of berberine supplementation on lipid profile and obesity indices: An umbrella review of meta-analysis

IF 2.4 Q3 NUTRITION & DIETETICS PharmaNutrition Pub Date : 2023-11-17 DOI:10.1016/j.phanu.2023.100364
Zeynab Kavyani , Erfan shahhosseini , Amir Hossein Moridpour , Maryam Falahatzadeh , Mahdi Vajdi , Vali Musazadeh , Gholamreza Askari
{"title":"The effect of berberine supplementation on lipid profile and obesity indices: An umbrella review of meta-analysis","authors":"Zeynab Kavyani ,&nbsp;Erfan shahhosseini ,&nbsp;Amir Hossein Moridpour ,&nbsp;Maryam Falahatzadeh ,&nbsp;Mahdi Vajdi ,&nbsp;Vali Musazadeh ,&nbsp;Gholamreza Askari","doi":"10.1016/j.phanu.2023.100364","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Several meta-analyses reported berberine supplementation improves lipid profile and obesity indices, but findings remain conflicting.</p></div><div><h3>Aim of the review</h3><p>Therefore, we carried out an umbrella review of meta-analysis in order to examine whether berberine supplementation on lipid profile and obesity indices.</p></div><div><h3>Methods</h3><p>A systematic search was conducted on PubMed, Scopus<span>, Embase, Web of Science, and Google Scholar up to December 2022.</span></p></div><div><h3>Results</h3><p>Berberine supplementation was effective in reducing low-density lipoprotein cholesterol (LDL-C) (ES<sub>SMD</sub><span>: −0.56 mg/dL; 95% CI: −0.74 to −0.38, p &lt; 0.001), total cholesterol (TC) (ES</span><sub>SMD</sub><span>: −0.57 mg/dL, 95% CI: −0.69 to −0.44, p &lt; 0.001), triglyceride (TG) (ES</span><sub>SMD</sub>: −0.47 mg/dL; 95% CI: −0.56 to −0.37, p &lt; 0.001) according to SMD analysis. In addition, berberine significantly increased high-density lipoprotein cholesterol (HDL-C) (ES<sub>SMD</sub>: 0.14 mg/dL; 95% CI: 0.08–0.20, p &lt; 0.001) according to SMD analysis. Also, the findings showed that berberine resulted in a significant decrease in waist circumference (WC) (ES <sub>WMD</sub>: −1.30 cm; 95% CI: −1.91 to −0.69, p &lt; 0.001), but not in body weight (ES<sub>WMD</sub><span>: −0.86 kg; 95% CI: −2.12 to 0.41), body mass index (BMI) (ES</span><sub>WMD</sub>: −0.57 kg/m<sup>2</sup>; 95% CI: −1.21 to 0.06, p = 0.078, and ES<sub>SMD</sub>: −0.28 kg/m<sup>2</sup>; 95% CI: −070 to 0.14, p = 0.186), and waist-to-height ratio (WHR) levels (ES<sub>SMD</sub>: −0.40; 95% CI: −1.26 to 0.47, p = 0.369).</p></div><div><h3>Conclusion</h3><p>The results of our study revealed that the supplementation of berberine could be effective in improving WC, and lipid profile, although the impact of this supplement on obesity indices needs further investigation.</p></div>","PeriodicalId":20049,"journal":{"name":"PharmaNutrition","volume":"26 ","pages":"Article 100364"},"PeriodicalIF":2.4000,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmaNutrition","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213434423000361","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Several meta-analyses reported berberine supplementation improves lipid profile and obesity indices, but findings remain conflicting.

Aim of the review

Therefore, we carried out an umbrella review of meta-analysis in order to examine whether berberine supplementation on lipid profile and obesity indices.

Methods

A systematic search was conducted on PubMed, Scopus, Embase, Web of Science, and Google Scholar up to December 2022.

Results

Berberine supplementation was effective in reducing low-density lipoprotein cholesterol (LDL-C) (ESSMD: −0.56 mg/dL; 95% CI: −0.74 to −0.38, p < 0.001), total cholesterol (TC) (ESSMD: −0.57 mg/dL, 95% CI: −0.69 to −0.44, p < 0.001), triglyceride (TG) (ESSMD: −0.47 mg/dL; 95% CI: −0.56 to −0.37, p < 0.001) according to SMD analysis. In addition, berberine significantly increased high-density lipoprotein cholesterol (HDL-C) (ESSMD: 0.14 mg/dL; 95% CI: 0.08–0.20, p < 0.001) according to SMD analysis. Also, the findings showed that berberine resulted in a significant decrease in waist circumference (WC) (ES WMD: −1.30 cm; 95% CI: −1.91 to −0.69, p < 0.001), but not in body weight (ESWMD: −0.86 kg; 95% CI: −2.12 to 0.41), body mass index (BMI) (ESWMD: −0.57 kg/m2; 95% CI: −1.21 to 0.06, p = 0.078, and ESSMD: −0.28 kg/m2; 95% CI: −070 to 0.14, p = 0.186), and waist-to-height ratio (WHR) levels (ESSMD: −0.40; 95% CI: −1.26 to 0.47, p = 0.369).

Conclusion

The results of our study revealed that the supplementation of berberine could be effective in improving WC, and lipid profile, although the impact of this supplement on obesity indices needs further investigation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
补充小檗碱对血脂和肥胖指数的影响:荟萃分析综述
背景:一些荟萃分析报道,补充小檗碱可以改善血脂和肥胖指数,但研究结果仍然存在矛盾。因此,我们对荟萃分析进行了综合综述,以检验黄连素补充剂是否对血脂和肥胖指数有影响。方法系统检索截至2022年12月的PubMed、Scopus、Embase、Web of Science、Google Scholar等数据库。结果补充小檗碱能有效降低低密度脂蛋白胆固醇(LDL-C) (ESSMD: - 0.56 mg/dL;95% CI: - 0.74至- 0.38,p <0.001),总胆固醇(TC) (ESSMD: - 0.57 mg/dL, 95% CI: - 0.69 ~ - 0.44, p <0.001),甘油三酯(TG) (ESSMD:−0.47 mg/dL;95% CI: - 0.56 ~ - 0.37, p <0.001),根据SMD分析。此外,小檗碱显著增加高密度脂蛋白胆固醇(HDL-C) (ESSMD: 0.14 mg/dL;95% CI: 0.08-0.20, p <0.001),根据SMD分析。此外,研究结果表明,小檗碱导致腰围(WC)显著降低(ES WMD: - 1.30 cm;95% CI: - 1.91 ~ - 0.69, p <0.001),但与体重无关(ESWMD:−0.86 kg;95% CI:−2.12 ~ 0.41),体重指数(BMI) (ESWMD:−0.57 kg/m2;95% CI:−1.21 ~ 0.06,p = 0.078, ESSMD:−0.28 kg/m2;95% CI:−070 ~ 0.14,p = 0.186),腰高比(WHR)水平(ESSMD:−0.40;95% CI:−1.26 ~ 0.47,p = 0.369)。结论本研究结果显示,添加小檗碱可有效改善体重和血脂,但对肥胖指标的影响有待进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
PharmaNutrition
PharmaNutrition Agricultural and Biological Sciences-Food Science
CiteScore
5.70
自引率
3.10%
发文量
33
审稿时长
12 days
期刊最新文献
A therapeutic approach to identify leading molecules from natural products and therapeutic targets in CKD by network pharmacology Efficacy and safety of crocin supplementation in patients with central serous chorioretinopathy, a pilot randomized double blinded clinical trial Dietitians’ knowledge and practice regarding inflammaging and related interventions: A pilot survey Exploring the molecular mechanisms and therapeutic benefits of L-theanine in counteracting inflammation Enhanced absorption of omega-3 fatty acids from a novel krill oil-derived phospholipid formulation compared to fish oil ethyl esters: A randomized, two-way crossover pharmacokinetic study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1